Literature DB >> 2787729

The prevalence of pulmonary hypertension in the United States. Adult population estimates obtained from measurements of chest roentgenograms from the NHANES II Survey.

S Rich1, E Chomka, L Hasara, K Hart, T Drizd, E Joo, P S Levy.   

Abstract

Because a definitive diagnosis of pulmonary hypertension requires cardiac catheterization, there have been no data on the prevalence of pulmonary hypertension in the general population. The diameter of the right descending pulmonary artery, as measured from chest roentgenograms, has been used by clinicians as a noninvasive indicator of pulmonary hypertension. Chest roentgenograms from the Second National Health and Nutrition Examination Survey, a sample survey of the US civilian noninstitutional population, were used in conjunction with estimates of sensitivity and specificity of this technique determined from patients who underwent right heart catheterization to estimate the prevalence of pulmonary hypertension (mean pulmonary artery pressure greater than 20 mm Hg at rest) in the US population aged 25 years and older. The prevalence is estimated to be very low in the population at large, primarily because of the low prevalence in women of all ages. The prevalence in men is 13.4 percent above age 34, and increases to 28.2 percent above age 64. Thus, in elderly men, pulmonary hypertension is relatively common and may have an important impact in the management of this age group.

Entities:  

Mesh:

Year:  1989        PMID: 2787729     DOI: 10.1378/chest.96.2.236

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  10 in total

1.  Time-resolved magnetic resonance angiography: evaluation of intrapulmonary circulation parameters in pulmonary arterial hypertension.

Authors:  Hyun J Jeong; Parmede Vakil; John J Sheehan; Sanjiv J Shah; Michael Cuttica; James C Carr; Timothy J Carroll; Amir Davarpanah
Journal:  J Magn Reson Imaging       Date:  2011-01       Impact factor: 4.813

2.  The effect of pulmonary hypertension on inpatient outcomes of laparoscopic procedures.

Authors:  Loka Thangamathesvaran; Sarah J Armenia; Aziz M Merchant
Journal:  Updates Surg       Date:  2018-06-27

3.  Epidemiology of Cardiac Amyloidosis-Associated Heart Failure Hospitalizations Among Fee-for-Service Medicare Beneficiaries in the United States.

Authors:  Lauren G Gilstrap; Francesca Dominici; Yun Wang; M Samir El-Sady; Amitoj Singh; Marcelo F Di Carli; Rodney H Falk; Sharmila Dorbala
Journal:  Circ Heart Fail       Date:  2019-06-07       Impact factor: 8.790

4.  CT scanning in the evaluation of pulmonary hypertension.

Authors:  Jennifer C Kam; Justin Pi; Vikram Doraiswamy; Yaser Elnahar; Sami Abdul-Jawad; Vincent A DeBari; Alan J Klukowicz; Fayez Shamoon; Richard A Miller
Journal:  Lung       Date:  2013-05-29       Impact factor: 2.584

5.  Mutations and polymorphisms in hemoglobin genes and the risk of pulmonary hypertension and death in sickle cell disease.

Authors:  James G Taylor; Diana Ackah; Crystal Cobb; Nick Orr; Melanie J Percy; Vandana Sachdev; Roberto Machado; Oswaldo Castro; Gregory J Kato; Stephen J Chanock; Mark T Gladwin
Journal:  Am J Hematol       Date:  2008-01       Impact factor: 10.047

Review 6.  [Chronic pulmonary embolism--radiological imaging and differential diagnosis].

Authors:  E Coppenrath; P Herzog; U Attenberger; M Reiser
Journal:  Radiologe       Date:  2007-08       Impact factor: 0.635

7.  Protection of oral hydrogen water as an antioxidant on pulmonary hypertension.

Authors:  Bin He; Yufeng Zhang; Bo Kang; Jian Xiao; Bing Xie; Zhinong Wang
Journal:  Mol Biol Rep       Date:  2013-08-18       Impact factor: 2.316

8.  Pulmonary arterial hypertension in critically ill elderly patients.

Authors:  Yun-Yun Zhang; Fan Xu; Ming Chu; Li-Qing Bi
Journal:  Pak J Med Sci       Date:  2017 Jan-Feb       Impact factor: 1.088

9.  Trends in pulmonary hypertension mortality and morbidity.

Authors:  Alem Mehari; Orlando Valle; Richard F Gillum
Journal:  Pulm Med       Date:  2014-06-01

10.  Early- versus late-onset systemic sclerosis: differences in clinical presentation and outcome in 1037 patients.

Authors:  Marco A Alba; César Velasco; Carmen Pilar Simeón; Vicent Fonollosa; Luis Trapiella; María Victoria Egurbide; Luis Sáez; María Jesús Castillo; José Luis Callejas; María Teresa Camps; Carles Tolosa; Juan José Ríos; Mayka Freire; José Antonio Vargas; Gerard Espinosa
Journal:  Medicine (Baltimore)       Date:  2014-03       Impact factor: 1.889

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.